Our exclusive Life Sciences focus gives us a distinct advantage.
King of Prussia, PA (PRWEB) August 04, 2016
Tunnell Consulting, Inc. announced that it has formally launched a business unit, Turesol, that is dedicated to providing temporary staffing solutions to pharmaceutical and biotech companies. Turesol is designed and prepared to respond to those temporary resource needs with speed and competitive pricing. Tunnell’s decision to invest in Turesol is in response to a growing trend whereby companies wish to have a more nimble, flexible workforce with access to the right experts when they need them and only then. Importantly, working with Turesol provides our clients the assurance that that their temporary workforce is in full compliance with the Affordable Care Act and other critical IRS and Labor requirements.
Philippe Cini, a long time Tunnell executive and pharmaceutical industry professional, has been asked to lead Turesol. “I am delighted to lead this newly formed business unit of Tunnell. The business world is evolving rapidly. Our clients need very capable resources at a moment’s notice for a finite period of time. Turesol has been designed with that purpose in mind. Our exclusive Life Sciences focus gives us a distinct advantage over other resource providers. We speak the same expert language as our clients and through our extensive network of pharma industry professionals, we can rapidly identify the right specialist for the job at hand”, said Philippe.